Cointime

MedSciences Capital

investment firm

About

MedSciences Capital (MSC) is a ven­ture cap­i­tal provider to early- and mid-stage com­pa­nies devel­op­ing inno­v­a­tive prod­ucts in the

Highlights

Investments
7
Lead Investments
1
Exits
3
Employee Profiles
1

Details

Founded date
Jan 1, 2006
Operating Status
Active
Also Known As
MSC
Investor Type
Venture Capital

MedSciences Capital (MSC) is a ven­ture cap­i­tal provider to early- and mid-stage com­pa­nies devel­op­ing inno­v­a­tive prod­ucts in the med­ical life sci­ences sec­tor.

Investments

Number of Investments
Number of Lead Investments
7
1
MedSciences Capital has made 7 investments. Their most recent investment was on Apr 29, 2014, when Mucosis raised $6.90M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 29, 2014 Mucosis
Series Unknown $6.90M Biotechnology —
Jan 25, 2012 Prosensa
Series Unknown €23M Biotechnology —
Jan 1, 2011 Net Medical
Seed — Health Care Yes
May 19, 2010 Pronota
Series B €1.50M Biotechnology —
Feb 23, 2010 Organ Assist
Series Unknown €1.70M Health Care —
Show More

Employee Profiles

Number of Employee Profiles
1
MedSciences Capital has 1 current employee profiles, including Executive Otto Postma
Otto Postma
Executive

Exits

MedSciences Capital has had 3 exits. MedSciences Capital most notable exits include Kiadis Pharma ,   Prosensa

Date Company Name Exit Type Industry
Jul 10, 2015 Kiadis Pharma M&A Biopharma Detail
Jun 27, 2013 Prosensa M&A Biotechnology Detail
Oct 31, 2012 Net Medical M&A Health Care Detail
Cointime
Insight
Features
RSS
Company